Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/test-epi-composition/ and changes regularly. See the Directory of published versions
Full name:
Authorised dose form:
Legal status of supply:
Domain:
Resource status:
Product classification:
Document Details
Generated Narrative: Bundle TEST PURPOSES ONLY - insulin
Language: en
Profile: Bundle - ePI
Final Document at 2022-02-16 13:28:17+0000 by Organization ACME industry for Bundle: identifier = http://ema.europa.eu/identifier#None; type = document; timestamp = 2023-06-27 10:09:22+0000
Document Subject
Generated Narrative: MedicinalProductDefinition mp9db488ea4436e9188ae22052d9c51b50
identifier: http://ema.europa.eu/identifier
/EU/1/17/1203/001
type: Medicinal Product
domain: Human use
status: active
legalStatusOfSupply: Medicinal product subject to medical prescription
name
productName: Insulin lispro Sanofi 100 units/ml solution for injection in vial
type: Full name
part
part: nan
type: Invented name part
part
part: nan
type: Scientific name part
part
part: nan
type: Strength part
part
part: nan
type: Pharmaceutical dose form part
Usages
Country Jurisdiction Language EU EU en
Document Content
Generated Narrative: Composition composition-en-9db488ea4436e9188ae22052d9c51b50
Language: en
Profile: Composition (ePI)
identifier: http://ema.europa.eu/identifier
/EU/1/17/1203/001
status: Final
type: Package Leaflet
category: Raw
date: 2022-02-16 13:28:17+0000
author: Organization ACME industry
title: TEST PURPOSES ONLY - insulin
Mode | Time |
Official | 2022-02-16 13:28:17+0000 |
What is in this leaflet
Insulin lispro Sanofi is used to treat diabetes. It works more quickly than normal human insulin because the insulin molecule has been changed slightly.
You get diabetes if your pancreas does not make enough insulin to control the level of glucose in your blood. Insulin lispro Sanofi is a substitute for your own insulin and is used to control glucose in the long term. It works very quickly and lasts a shorter time than soluble insulin (2 to 5 hours). You should normally use Insulin lispro Sanofi within 15 minutes of a meal.
Your doctor may tell you to use Insulin lispro Sanofi as well as a longer-acting insulin. Each kind of insulin comes with another patient information leaflet to tell you about it. Do not change your insulin unless your doctor tells you to. Be very careful if you do change insulin.
Insulin lispro Sanofi is suitable for use in adults and children.
Do not use Insulin lispro Sanofi
Warnings and precautions Record the brand name ( Insulin lispro Sanofi ) and Lot number (included on the outer cartons and labels of each vial, cartridge and pre-filled pen) of the product you are using and provide this information when reporting any side effects.
Skin changes at the injection site The injection site should be rotated to prevent skin changes such as lumps under the skin. The insulin may not work very well if you inject into a lumpy area (see How to use Insulin lispro Sanofi). Contact your doctor if you are currently injecting into a lumpy area before you start injecting in a different area. Your doctor may tell you to check your blood sugar more closely, and to adjust your insulin or your other antidiabetic medications dose.
Talk to your doctor, pharmacist or nurse before using Insulin lispro Sanofi:
Other medicines and Insulin lispro Sanofi Your insulin needs may change if you are taking
Tell your doctor if you are taking, have recently taken or might take any other medicines (see also section Warnings and precautions ).
Insulin lispro Sanofi with alcohol
Your blood sugar levels may change if you drink alcohol. Therefore the amount of insulin needed may change.
Pregnancy and breast-feeding If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine. The amount of insulin you need usually falls during the first three months of pregnancy and increases for the remaining six months. If you are breast-feeding, you may need to alter your insulin intake or diet.
Driving and using machines Your ability to concentrate and react may be reduced if you have hypoglycaemia. Please keep this possible problem in mind in all situations where you might put yourself and others at risk (e.g. driving a car or using machines). You should contact your doctor about the advisability of driving if you have:
Insulin lispro Sanofi contains sodium This medicine contains less than 1 mmol (23 mg) sodium per dose, that is to say essentially sodium- free .
Always check the pack and the vial label for the name and type of the insulin when you get it from your pharmacy. Make sure you get the Insulin lispro Sanofi that your doctor has told you to use.
Always use this medicine exactly as your doctor has told you. Check with your doctor if you are not sure.
Dose
Preparing Insulin lispro Sanofi
Injecting Insulin lispro Sanofi
Using Insulin lispro Sanofi in an infusion pump
If you use more Insulin lispro Sanofi than you should If you use more Insulin lispro Sanofi than you need or are unsure how much you have injected, a low blood sugar may occur. Check your blood sugar. If your blood sugar is low (mild hypoglycaemia), eat glucose tablets, sugar or drink a sugary drink. Then eat fruit, biscuits, or a sandwich, as your doctor has advised you and have some rest. This will often get you over mild hypoglycaemia or a minor insulin overdose. If you get worse and your breathing is shallow and your skin gets pale, tell your doctor at once. A glucagon injection can treat quite severe hypoglycaemia. Eat glucose or sugar after the glucagon injection. If you do not respond to glucagon, you will have to go to hospital. Ask your doctor to tell you about glucagon.
If you forget to use Insulin lispro Sanofi If you use less Insulin lispro Sanofi than you need or are unsure how much you have injected, a high blood sugar may occur. Check your blood sugar.
If hypoglycaemia (low blood sugar) or hyperglycaemia (high blood sugar) is not treated, they can be very serious and cause headaches, feeling sick (nausea), being sick (vomiting), loss of fluids (dehydration), unconsciousness, coma or even death (see Hypoglycaemia and Hyperglycaemia and diabetic ketoacidosis in section 4 Possible Side Effects ).
Three simple steps to avoid hypoglycaemia or hyperglycaemia are:
If you stop using Insulin lispro Sanofi
If you use less Insulin lispro Sanofi than you need, a high blood sugar may occur. Do not change your insulin unless your doctor tells you to.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them. Systemic allergy is rare (may affect up to 1 in 1,000 people). The symptoms are as follows:
If you think you are having this sort of insulin allergy with Insulin lispro Sanofi, tell your doctor at once.
Local allergy is common (may affect up to 1 in 10 people). Some people get redness, swelling or itching around the area of the insulin injection. This usually clears up in anything from a few days to a few weeks. If this happens to you, tell your doctor.
Skin changes at the injection site Lipodystrophy is uncommon (it may affect up to 1 in 100 people). If you inject insulin too often at the same place, the fatty tissue may either shrink (lipoatrophy) or thicken (lipohypertrophy). Lumps under the skin may also be caused by build-up of a protein called amyloid (cutaneous amyloidosis; how often this occurs is not known). The insulin may not work very well if you inject into a lumpy area. Change the injection site with each injection to help prevent these skin changes.
Oedema (e.g. swelling in arms, ankles; fluid retention) has been reported, particularly at the start of insulin therapy or during a change in therapy to improve control of your blood glucose.
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.
Common problems of diabetes
A. Hypoglycaemia
Hypoglycaemia (low blood sugar) means there is not enough sugar in the blood. This can be caused if:
Alcohol and some medicines can affect your blood sugar levels (see section 2).
The first symptoms of low blood sugar usually come on quickly and include the following:
While you are not confident about recognising your warning symptoms, avoid situations, e.g. driving a car, in which you or others would be put at risk by hypoglycaemia.
B. Hyperglycaemia and diabetic ketoacidosis Hyperglycaemia (too much sugar in the blood) means that your body does not have enough insulin. Hyperglycaemia can be brought about by:
Hyperglycaemia can lead to diabetic ketoacidosis. The first symptoms come on slowly over many hours or days. The symptoms include the following:
Severe symptoms are heavy breathing and a rapid pulse. Get medical help immediately.
C. Illness If you are ill, especially if you feel sick or are sick, the amount of insulin you need may change. Even when you are not eating normally, you still need insulin. Test your urine or blood, follow your sick rules , and tell your doctor.
Keep out of the reach and sight of children.
Do not use Insulin lispro Sanofi after the expiry date which is stated on the label and the carton. The expiry date refers to the last day of that month.
Before the first use store your medicine in a refrigerator (2 C 8 C). Do not freeze. Keep the vial in the outer carton in order to protect from light.
Keep your vial in use at room temperature (below 30 C) and dispose of after 4 weeks. Do not store the vial in a refrigerator. Keep the vial in the outer carton in order to protect from light.
Do not use Insulin lispro Sanofi if it is coloured or it has solid pieces in it. You must use it only if it looks like water. Check this each time you inject yourself.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
What Insulin lispro Sanofi contains
What Insulin lispro Sanofi looks like and contents of the pack
Insulin lispro Sanofi, solution for injection in a vial is a clear, colourless, aqueous solution Each vial contains 10 ml. The Insulin lispro Sanofi in a vial comes in a pack of 1 vial or 5 vials. Not all pack sizes may be marketed.
Marketing Authorisation Holder Sanofi Winthrop Industrie, 82 avenue Raspail, 94250 Gentilly, France
Manufacturer
Sanofi-Aventis Deutschland GmbH, D-65926 Frankfurt am Main, Germany. For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder.
Belgi /Belgique/Belgien Sanofi Belgium T l/Tel: +32 (0)2 710 54 Lietuva Swixx Biopharma UAB Tel: +370 5 236 91
Swixx Biopharma EOOD .: +359 (0)2 4942 Luxembourg/Luxemburg Sanofi Belgium
T l/Tel: +32 (0)2 710 54 00 (Belgique/Belgien)
esk republika sanofi-aventis, s.r.o. Tel: +420 233 086 Magyarorsz g SANOFI-AVENTIS Zrt., Tel.: +36 1 505 0Danmark Sanofi A/S Tlf: +45 45 16 70 Malta Sanofi S.r.l. Tel: +39 02 39394Deutschland Sanofi-Aventis Deutschland GmbH Tel.: 0800 52 52 Tel. aus dem Ausland: +49 69 305 21 Nederland Sanofi B.V. Tel: +31 20 245 4Eesti Swixx Biopharma O
Tel: +372 640 10 Norge sanofi-aventis Norge AS Tlf: +47 67 10 71
Sanofi-Aventis
: +30 210 900 16 sterreich sanofi-aventis GmbH Tel: +43 1 80 185 0
Espa a sanofi-aventis, S.A. Tel: +34 93 485 94 Polska sanofi-aventis Sp. z o.o. Tel.: +48 22 280 00 France Sanofi Winthrop Industrie T l: 0 800 222 Appel depuis l tranger: +33 1 57 63 23 Portugal Sanofi - Produtos Farmac uticos, Lda Tel: +351 21 35 89 Hrvatska Swixx Biopharma d.o.o. Tel: +385 1 2078 Rom nia Sanofi Romania SRL Tel: +40 (0) 21 317 31 Ireland sanofi-aventis Ireland Ltd. T/A SANOFI Tel: +353 (0) 1 403 56 Slovenija Swixx Biopharma d.o.o. Tel: +386 1 235 51 sland Vistor hf. S mi: +354 535 7Slovensk republika Swixx Biopharma s.r.o. Tel: +421 2 208 33 Italia Sanofi S.r.l. Tel: 800 13 12 12 (domande di tipo tecnico)
800.536389 (altre domande)
Suomi/Finland Sanofi Oy Puh/Tel: +358 (0) 201 200
C.A Papaellinas Ltd. : +357 22 741Sverige Sanofi AB Tel: +46 (0)8 634 50 Latvija Swixx Biopharma SIA Tel: +371 6616 47 United Kingdom (Northern Ireland) Sanofi-aventis Ireland Ltd. T/A SANOFI Tel: +44 (0) 800 035 2This leaflet was last revised in
Other source of information Detailed information on this medicine is available on the European Medicines Agency web site:
Entry 1 - fullUrl = Composition/composition-en-9db488ea4436e9188ae22052d9c51b50
Resource Composition:
Generated Narrative: Composition composition-en-9db488ea4436e9188ae22052d9c51b50
Language: en
Profile: Composition (ePI)
identifier:
http://ema.europa.eu/identifier
/EU/1/17/1203/001status: Final
type: Package Leaflet
category: Raw
date: 2022-02-16 13:28:17+0000
author: Organization ACME industry
title: TEST PURPOSES ONLY - insulin
Attesters
Mode Time Official 2022-02-16 13:28:17+0000
Entry 2 - fullUrl = MedicinalProductDefinition/mp9db488ea4436e9188ae22052d9c51b50
Resource MedicinalProductDefinition:
Generated Narrative: MedicinalProductDefinition mp9db488ea4436e9188ae22052d9c51b50
identifier:
http://ema.europa.eu/identifier
/EU/1/17/1203/001type: Medicinal Product
domain: Human use
status: active
legalStatusOfSupply: Medicinal product subject to medical prescription
name
productName: Insulin lispro Sanofi 100 units/ml solution for injection in vial
type: Full name
part
part: nan
type: Invented name part
part
part: nan
type: Scientific name part
part
part: nan
type: Strength part
part
part: nan
type: Pharmaceutical dose form part
Usages
Country Jurisdiction Language EU EU en